198 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Programme ‘Outcome Information for Shared Decision-Making’ - factsheet

Publication | 19-10-2017

Project: ‘ICHOM as an accelerator for outcome information’ - factsheet

Publication | 19-10-2017

Acarizax® in cases of allergic rhinitis due to house dust mite

Zorginstituut Nederland carried out an assessment of whether the medicinal product Acarizax® is interchangeable with a drug...

Report | 26-06-2017

Cetuximab (Erbitux®) for the treatment of metastatic colorectal cancer

Zorginstituut Nederland has carried out a re-assessment of the medicinal product cetuximab (Erbitux®), whereby they came to the...

Report | 26-06-2017

A paradigm shift in perception, learning and action - core of the second advice of the Committee Innovation Health Care Professions & Education

Translation of the core of the second advice of The Committee Innovation Health Care Professions & Education.

Report | 18-05-2017

Tenofovir alafenamide (Vemlidy®) for the treatment of chronic hepatitis B infection

Zorginstituut Nederland carried out an assessment of the medicine tenofovir alafenamide (Vemlidy®). Based on the criteria of...

Report | 26-04-2017

Migalastat (Galafold) for the treatment of Fabry's disease

Zorginstituut Nederland carried out an assessment of whether, based on the criteria of the Medicines Reimbursement System...

Report | 25-04-2017

Elosulfase alfa (Vimizim) for the treatment of Morquio A syndrome

Zorginstituut Nederland carried out a reassessment of the medicinal product elosulfase alfa (Vimizim).

Report | 24-04-2017

Ibrutinib (Imbruvica®) for the treatment of chronic lymphatic leukaemia

Zorginstituut Nederland carried out an assessment of the medicinal product ibrutinib (Imbruvica®), for the first-line treatment...

Report | 24-04-2017

Cysteamine with delayed release (Procysbi®)

Zorginstituut Nederland carried out an assessment of the medicine cysteamine with delayed release (Procysbi®) whereby they...

Report | 23-03-2017